Free Trial
OTCMKTS:SARTF

Sartorius (SARTF) Stock Price, News & Analysis

Sartorius logo
$213.06 0.00 (0.00%)
As of 10/10/2025

About Sartorius Stock (OTCMKTS:SARTF)

Advanced

Key Stats

Today's Range
$213.06
$213.06
50-Day Range
$181.58
$213.06
52-Week Range
$165.00
$243.35
Volume
N/A
Average Volume
18 shs
Market Capitalization
N/A
P/E Ratio
129.92
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
Strong Buy

Company Overview

Receive SARTF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Sartorius and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

SARTF Stock News Headlines

Buy this stock before Tesla’s November 6 announcement
The End of Tesla? "Hold onto your Tesla stock." That's the message insiders at Tesla have been giving staff, as the world's biggest car firm prepares to launch a "mind blowing" new product. It has nothing to do with EVs, or self-driving cars. In fact, it's not a car at all...tc pixel
See More Headlines

SARTF Stock Analysis - Frequently Asked Questions

Sartorius' stock was trading at $184.00 at the start of the year. Since then, SARTF stock has increased by 15.8% and is now trading at $213.06.

Sartorius (OTCMKTS:SARTF) announced its quarterly earnings results on Tuesday, July, 22nd. The company reported $1.38 EPS for the quarter, missing the consensus estimate of $1.49 by $0.11. The company earned $1.04 billion during the quarter, compared to analysts' expectations of $977.90 million. Sartorius had a net margin of 3.00% and a trailing twelve-month return on equity of 7.79%.

Sartorius subsidiaries include Novasep’s chromatography division, ALS Automated Lab Solutions GmbH, Xell AG, CellGenix Inc., WaterSep BioSeparations LLC, BIA Separations, Biological Industries, and more.

Shares of SARTF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

Last Earnings
7/22/2025
Today
10/13/2025
Next Earnings (Estimated)
10/16/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Sector
Medical
Industry
MED INSTRUMENTS
Sub-Industry
N/A
Current Symbol
OTCMKTS:SARTF
Previous Symbol
NASDAQ:SARTF
CIK
N/A
Employees
13,528
Year Founded
1870

Profitability

EPS (Trailing Twelve Months)
$1.64
Trailing P/E Ratio
129.92
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$90.90 million
Net Margins
3.00%
Pretax Margin
6.67%
Return on Equity
7.79%
Return on Assets
2.98%

Debt

Debt-to-Equity Ratio
1.08
Current Ratio
1.39
Quick Ratio
0.88

Sales & Book Value

Annual Sales
$3.66 billion
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
N/A
Price / Book
N/A

Miscellaneous

Outstanding Shares
N/A
Free Float
N/A
Market Cap
N/A
Optionable
Not Optionable
Beta
1.01

Social Links

Reduce the Risk Cover

Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.

Get This Free Report

This page (OTCMKTS:SARTF) was last updated on 10/14/2025 by MarketBeat.com Staff
From Our Partners